229 related articles for article (PubMed ID: 28347831)
21. Early Enhancement of Neuroplasticity Index, the Ratio of Serum Brain-Derived Neurotrophic Factor Level to HAMD-24 Score, in Predicting the Long-Term Antidepressant Efficacy.
Zhang Y; Cui B; Wang T; Lu Y; Chen Z; Zou Z; Miao J; Zhao X; Yuan Y; Wang H; Chen G
Front Behav Neurosci; 2021; 15():712445. PubMed ID: 34776888
[No Abstract] [Full Text] [Related]
22. Molecular Mechanism and Clinical Relevance of Ketamine as Rapid-Acting Antidepressant.
Pešić V; Petrović J; M Jukić M
Drug Dev Res; 2016 Nov; 77(7):414-422. PubMed ID: 27546787
[TBL] [Abstract][Full Text] [Related]
23. Repeated Yueju, But Not Fluoxetine, Induced Sustained Antidepressant Activity in a Mouse Model of Chronic Learned Helplessness: Involvement of CaMKII Signaling in the Hippocampus.
Zou Z; Huang J; Yang Q; Zhang Y; Xu B; Wang P; Chen G
Evid Based Complement Alternat Med; 2022; 2022():1442578. PubMed ID: 35251201
[TBL] [Abstract][Full Text] [Related]
24. Lateral Habenular Burst Firing as a Target of the Rapid Antidepressant Effects of Ketamine.
Cui Y; Hu S; Hu H
Trends Neurosci; 2019 Mar; 42(3):179-191. PubMed ID: 30823984
[TBL] [Abstract][Full Text] [Related]
25. Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting Antidepressants.
Kadriu B; Greenwald M; Henter ID; Gilbert JR; Kraus C; Park LT; Zarate CA
Int J Neuropsychopharmacol; 2021 Jan; 24(1):8-21. PubMed ID: 33252694
[TBL] [Abstract][Full Text] [Related]
26. MAPK signaling correlates with the antidepressant effects of ketamine.
Réus GZ; Vieira FG; Abelaira HM; Michels M; Tomaz DB; dos Santos MA; Carlessi AS; Neotti MV; Matias BI; Luz JR; Dal-Pizzol F; Quevedo J
J Psychiatr Res; 2014 Aug; 55():15-21. PubMed ID: 24819632
[TBL] [Abstract][Full Text] [Related]
27. Antidepressant drug action--From rapid changes on network function to network rewiring.
Rantamäki T; Yalcin I
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():285-92. PubMed ID: 26066070
[TBL] [Abstract][Full Text] [Related]
28. Synaptic mechanisms underlying rapid antidepressant action of ketamine.
Kavalali ET; Monteggia LM
Am J Psychiatry; 2012 Nov; 169(11):1150-6. PubMed ID: 23534055
[TBL] [Abstract][Full Text] [Related]
29. Analysis of main constituents and mechanisms underlying antidepressant-like effects of Xiaochaihutang in mice.
Zhang K; Wang F; Yang JY; Wang LJ; Pang HH; Su GY; Ma J; Song SJ; Xiong ZL; Wu CF
J Ethnopharmacol; 2015 Dec; 175():48-57. PubMed ID: 26318746
[TBL] [Abstract][Full Text] [Related]
30. An update on ketamine and its two enantiomers as rapid-acting antidepressants.
Zhang K; Hashimoto K
Expert Rev Neurother; 2019 Jan; 19(1):83-92. PubMed ID: 30513009
[No Abstract] [Full Text] [Related]
31. Ketamine for Depression, 1: Clinical Summary of Issues Related to Efficacy, Adverse Effects, and Mechanism of Action.
Andrade C
J Clin Psychiatry; 2017 Apr; 78(4):e415-e419. PubMed ID: 28448702
[TBL] [Abstract][Full Text] [Related]
32. Is off-label repeat prescription of ketamine as a rapid antidepressant safe? Controversies, ethical concerns, and legal implications.
Zhang MW; Harris KM; Ho RC
BMC Med Ethics; 2016 Jan; 17():4. PubMed ID: 26768892
[TBL] [Abstract][Full Text] [Related]
33. Antidepressant-like effect of ethanol extract from Zuojin Pill, containing two herbal drugs of Rhizoma Coptidis and Fructus Evodiae, is explained by modulating the monoaminergic neurotransmitter system in mice.
Wang QS; Ding SL; Mao HP; Cui YL; Qi XJ
J Ethnopharmacol; 2013 Jul; 148(2):603-9. PubMed ID: 23702040
[TBL] [Abstract][Full Text] [Related]
34. Antidepressant effect of Yueju-Wan ethanol extract and its fractions in mice models of despair.
Wei XH; Cheng XM; Shen JS; Wang ZT
J Ethnopharmacol; 2008 May; 117(2):339-44. PubMed ID: 18343064
[TBL] [Abstract][Full Text] [Related]
35. Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression.
Koike H; Iijima M; Chaki S
Behav Brain Res; 2011 Oct; 224(1):107-11. PubMed ID: 21669235
[TBL] [Abstract][Full Text] [Related]
36. [Study on Yueju Wan for "different diseases with same treatment" based on integrative pharmacology].
Zhang W; Tang SH; Zhang Y; Li DF; Yang HJ; Zhang Y; Guo FF
Zhongguo Zhong Yao Za Zhi; 2018 Apr; 43(7):1352-1359. PubMed ID: 29728023
[TBL] [Abstract][Full Text] [Related]
37. The Role of Nitric Oxide in the Antidepressant Actions of 5-Aminoimidazole-4-Carboxamide-1-β-D-Ribofuranoside in Insulin-Resistant Mice.
Liu W; Wang Y; Li H; Ji L
Psychosom Med; 2016 Jan; 78(1):102-12. PubMed ID: 26569535
[TBL] [Abstract][Full Text] [Related]
38. The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf⁺/⁻ heterozygous null mice.
Lindholm JS; Autio H; Vesa L; Antila H; Lindemann L; Hoener MC; Skolnick P; Rantamäki T; Castrén E
Neuropharmacology; 2012 Jan; 62(1):391-7. PubMed ID: 21867718
[TBL] [Abstract][Full Text] [Related]
39. The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits.
Witkin JM; Monn JA; Schoepp DD; Li X; Overshiner C; Mitchell SN; Carter G; Johnson B; Rasmussen K; Rorick-Kehn LM
J Pharmacol Exp Ther; 2016 Jul; 358(1):71-82. PubMed ID: 27189960
[TBL] [Abstract][Full Text] [Related]
40. Rapid-onset antidepressant action of ketamine: potential revolution in understanding and future pharmacologic treatment of depression.
Drewniany E; Han J; Hancock C; Jones RL; Lim J; Nemat Gorgani N; Sperry JK; Yu HJ; Raffa RB
J Clin Pharm Ther; 2015 Apr; 40(2):125-30. PubMed ID: 25545040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
